RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 56 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,884,000 | -87.6% | 2,214,200 | -19.5% | 0.00% | -100.0% |
Q1 2022 | $15,158,000 | -43.1% | 2,751,000 | 0.0% | 0.00% | -25.0% |
Q4 2021 | $26,630,000 | -43.8% | 2,751,000 | +3.8% | 0.00% | -50.0% |
Q3 2021 | $47,400,000 | +33.9% | 2,651,000 | +82.8% | 0.01% | +33.3% |
Q2 2021 | $35,403,000 | -7.9% | 1,450,333 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $38,434,000 | +353.3% | 1,450,333 | +29.8% | 0.01% | +250.0% |
Q4 2020 | $8,478,000 | +51.5% | 1,117,000 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $5,596,000 | -16.2% | 1,117,000 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $6,680,000 | -14.8% | 1,117,000 | -36.6% | 0.00% | 0.0% |
Q1 2020 | $7,844,000 | -84.1% | 1,762,598 | -66.0% | 0.00% | -81.8% |
Q4 2019 | $49,182,000 | +104.6% | 5,177,000 | +69.1% | 0.01% | +83.3% |
Q3 2019 | $24,040,000 | -50.1% | 3,062,396 | 0.0% | 0.01% | -45.5% |
Q2 2019 | $48,171,000 | -13.1% | 3,062,396 | 0.0% | 0.01% | -15.4% |
Q1 2019 | $55,429,000 | +15.1% | 3,062,396 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $48,149,000 | -29.1% | 3,062,396 | +5.9% | 0.01% | -23.5% |
Q3 2018 | $67,869,000 | – | 2,892,396 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
Artal Group S.A. | 2,042,666 | $357 | 0.02% |
Virtu Financial LLC | 68,825 | $12 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
Citadel Advisors | 600 | $103 | 0.00% |
Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |